Last $0.0001 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 10/23/14 All times are local (Market data is delayed by at least 15 minutes).

caleco pharma corp (CAEH) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/28/14 - $0.0095
52 Week Low
10/23/14 - $0.0001
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CALECO PHARMA CORP (CAEH)

Related News

No related news articles were found.

caleco pharma corp (CAEH) Related Businessweek News

No Related Businessweek News Found

caleco pharma corp (CAEH) Details

Caleco Pharma Corp. engages in the acquisition and development of over-the-counter medication, and Food and Drug Administration approved pharmaceuticals. It owns a proprietary technology designed to treat moderate to severe liver maladies, such as elevated liver enzymes and the Hepatitis C viral infection (the Liver Health Formula) as an over-the-counter medication, and as the United States Food and Drug Administration approved pharmaceutical. The company’s intellectual property covering the Liver Health Formula comprises patent applications in the United States, Canada, and Europe, as well as four European Drug Master File applications. It also develops food supplements, hair and dermatological products, energy drinks, and chewing gum using the formulations of its Liver Health Formula. In addition, Caleco holds the right to develop, commercialize, market, and distribute five compounds, including AOF, AH-FLO, JHF, HGF, and NB-VAL40 derived from plant extracts in North and South America pursuant to a license agreement with Natac Biotech S.L., a Spanish biotechnology corporation engaged in the research and development of health related products. The company was formerly known as Blackstone Lake Minerals Inc. and changed its name to Caleco Pharma Corp. in August 2009. Caleco Pharma Corp. is based in Long Valley, New Jersey.

caleco pharma corp (CAEH) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

caleco pharma corp (CAEH) Key Developments

SEC Orders Hearings On Registration Suspension Or Revocation Against Caleco Pharma Corp. For Failure To Make Required Periodic Filings

Securities and Exchange Commission (SEC or the commission) instituted public administrative proceeding to determine whether to revoke or suspend for a period not exceeding twelve months the registration of each class of the securities of Caleco Pharma Corp. for failure to make required periodic filings with the Commission. In this Order, the Division of Enforcement (Division) alleges that the company was delinquent in its required periodic filings with the Commission. In this proceeding, instituted pursuant to Exchange Act Section 12(j), a hearing will be scheduled before an Administrative Law Judge. At the hearing, the judge will hear evidence from the Division and the company to determine whether the allegations of the Division contained in the Order, which the Division alleges constitute failures to comply with Exchange Act Section 13(a) and Rules 13a-1 and 13a-13 there under, are true. The judge in the proceeding will then determine whether the registrations pursuant to Exchange Act Section 12 of each class of the securities of the company should be revoked or suspended for a period not exceeding twelve months. The Commission ordered that the Administrative Law Judge in this proceeding issue an initial decision not later than 120 days from the date of service of the order instituting proceeding.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CAEH:US $0.00 USD 0.00

CAEH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CAEH.
View Industry Companies

Industry Analysis


Industry Average

Valuation CAEH Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CALECO PHARMA CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at